Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Photo Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113717038A reveals a green nickel/ketone dual-catalysis method for diaryl ether synthesis, offering cost reduction and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN119930443A details a visible light photocatalytic method for trifluoromethylation. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115838330B reveals a visible-light method for dicarboxylic acids using CO2. This breakthrough offers cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN109134326B details a mild, visible-light catalyzed synthesis of S-aryl thiosulfones using thiourea and metabisulfite, offering significant cost and safety advantages for pharmaceutical intermediate manufacturing.
Novel visible light method synthesizes 3-sulfonyl spirocyclic trienones using air oxidant. Reduces energy and metal waste for reliable pharmaceutical intermediate supply chains.
Patent CN113444005B details a green visible-light method for synthesizing glutaric acids from olefins and CO2, offering significant supply chain and cost advantages.
Novel benzophenone-catalyzed method eliminates noble metals. High yield (>95%) cyclopropanation for fragrance intermediates. Cost-effective and scalable synthesis.
Novel photocatalytic route for alpha,alpha-difluoro-beta-carbonyl sulfones using visible light. Offers mild conditions and broad substrate scope for pharma applications.
Patent CN110483406B reveals a mild photocatalytic route for N-difluoromethylation, offering significant cost reduction and scalability for API manufacturing supply chains.
Patent CN110698360A details a green visible-light method for amide synthesis. Discover cost-effective, metal-free manufacturing solutions for high-purity pharmaceutical intermediates.
Patent CN103910723A reveals a novel visible light catalytic method for indoloquinoline synthesis using cheap metal salts and air oxygen, offering significant cost and supply chain advantages.
Patent CN113603653A reveals a visible light-promoted method for seleno-oxazolidine-2,4-dione. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable green chemistry.
Novel visible-light method replaces expensive silver reagents, offering high-yield, scalable production for pharmaceutical intermediates.
Novel patent CN120118017A details blue LED catalysis for 3-selenocyanoindoles. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN106831603B reveals metal-free visible light synthesis for fluoropyrimidines, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113773227A details a visible-light mediated method for epsilon-cyano carboxylic acids using CO2. Offers cost-effective pharma intermediate manufacturing.
Patent CN114075108A details a metal-free visible light method for aldehyde deuteration, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Novel Ru/Ni dual-catalyzed method for cyano-enamines offers mild conditions and high selectivity, optimizing pharmaceutical intermediate supply chains.
Patent CN110950739A reveals a mild, room-temperature photocatalytic method for ortho-fluorination. Ideal for high-purity pharmaceutical and agrochemical intermediates with reduced costs.
Discover the novel photocatalytic decarboxylative coupling method from patent CN108912042B. Enables mild, scalable production of high-purity aryl ketones for pharma.